CD19 and systemic lupus erythematosus: On May 30, 2024, at the EULAR 2024, JW (Cayman) Therapeutics Co., Ltd. presented clinical data for Relma-cel injection, a CD19-targeted CAR-T cell therapy, in patients with active SLE.